Richard H. Jr. Grimm

Richard H. Jr. Grimm's AcademicInfluence.com Rankings

Philosophy

#9532

World Rank

#13107

Historical Rank

Logic

#6506

World Rank

#8030

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard H. Jr. Grimm's Degrees

Doctorate Medicine University of Pennsylvania

Why Is Richard H. Jr. Grimm Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard H. Jr. Grimm's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

K/DOQI clinical practice guidelines for chronic kidney disease (2002) (8858)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) (5253)
Effects of intensive glucose lowering in type 2 diabetes. (2008) (4946)
Effects of intensive blood-pressure control in type 2 diabetes mellitus. (2010) (3094)
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
Effects of combination lipid therapy in type 2 diabetes mellitus. (2010) (2425)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (2011) (2093)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). (2002) (1272)
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial (2010) (1192)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2002) (1039)
Long-term effects of intensive glucose lowering on cardiovascular outcomes. (2011) (950)
Treatment of Mild Hypertension Study: Final Results (1993) (945)
Feasibility of treating prehypertension with an angiotensin-receptor blocker. (2006) (894)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension (1997) (683)
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (1996) (573)
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. (1993) (553)
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. (2007) (530)
Effect of Aspirin on All‐Cause Mortality in the Healthy Elderly (2018) (511)
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. (2011) (457)
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. (2003) (431)
Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial (2010) (431)
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) (1997) (398)
Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. (1985) (363)
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). (1995) (351)
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. (2010) (330)
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). (1996) (326)
Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. (1981) (318)
Effect of Aspirin on Disability‐free Survival in the Healthy Elderly (2018) (318)
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. (2005) (313)
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2004) (310)
Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). (2002) (305)
Effect of Calcium and Vitamin D Supplementation on Blood Pressure: The Women's Health Initiative Randomized Trial (2008) (267)
Excerpts from the United States Renal Data System 2006 Annual Data Report. (2007) (263)
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. (2006) (262)
Blood Pressure and Mortality Among Men With Prior Myocardial Infarction (1995) (245)
Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women’s Health Initiative (2000) (232)
Echocardiographic Correlates of Left Ventricular Structure Among 844 Mildly Hypertensive Men and Women in the Treatment of Mild Hypertension Study (Tomhs) (1993) (232)
Community-wide prevention of cardiovascular disease: education strategies of the Minnesota Heart Health Program. (1986) (227)
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial (2014) (221)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease (2003) (215)
Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. (1997) (206)
Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. (1997) (204)
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. (1997) (190)
Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. (1987) (182)
Chronic congestive heart failure in coronary artery disease: clinical criteria. (1977) (178)
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2006) (165)
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. (2005) (163)
Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. (1984) (162)
Nutritional Therapy for High Blood Pressure: Final Report of a Four-Year Randomized Controlled Trial— The Hypertension Control Program (1987) (158)
Long-term effects on plasma lipids of diet and drugs to treat hypertension (1996) (157)
An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk (2011) (154)
Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes (2016) (148)
Reduced vascular compliance as a marker for essential hypertension. (1991) (148)
Multiple risk factor intervention trial (MRFIT). (1981) (139)
Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). (1995) (138)
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. (1996) (136)
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. (1995) (129)
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. (2003) (128)
Serum calcium fractions in essential hypertensive and matched normotensive subjects. (1986) (127)
The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. (1990) (124)
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. (2007) (118)
Leukocyte count and risk of major coronary heart disease events. (1992) (117)
The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. (1990) (117)
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study (2017) (117)
Postural Hypotension and Postural Dizziness in Elderly Women: The Study of Osteoporotic Fractures (1992) (116)
Evaluation of patient-care protocol use by various providers. (1975) (114)
Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. (1995) (111)
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2001) (110)
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes (2017) (108)
The relationship of white blood cell count to other cardiovascular risk factors. (1990) (108)
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. (2010) (106)
Excerpts from the United States Renal Data System 1996 Annual Data Report. (2003) (100)
The white blood cell count and risk for coronary heart disease. (1992) (94)
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance (2016) (89)
Excerpts from the United States Renal Data System 1998 Annual Data Report. (1998) (88)
Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. (1992) (85)
Recruitment of participants for the multiple risk factor intervention trial (MRFIT). (1987) (82)
Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS). (1987) (81)
Dieting to reduce body weight for controlling hypertension in adults. (2001) (81)
Prevention of Post‐transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group 1 (2002) (77)
Is Postmenopausal Estrogen Therapy Associated With Neuromuscular Function or Falling in Elderly Women (1995) (76)
The systolic hypertension in the elderly program (1994) (75)
Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT) (1987) (75)
Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. (1986) (74)
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. (2012) (72)
C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study (2014) (70)
Cardiac Resynchronization Therapy in Non‐Left Bundle Branch Block Morphologies (2009) (70)
Long-Term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS) (1998) (69)
Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups. (1985) (67)
The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: the Oslo Youth Study. (1985) (67)
Stop smoking advice by physicians: a feasible approach? (1987) (63)
Do hypertensive patients have a different diurnal pattern of electrolyte excretion? (1987) (60)
Sodium Chloride Raises Blood Pressure in Normotensive Subjects The Study of Sodium and Blood Pressure (1991) (60)
Dieting to reduce body weight for controlling hypertension in adults. (2000) (59)
Untreated HIV Infection and Large and Small Artery Elasticity (2009) (59)
Antihypertensive therapy: taking lipids into consideration. (1991) (56)
Cholesterol Lowering in the Elderly: Results of the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study (1994) (54)
Population-derived comparisons of ambulatory and office blood pressures. Implications for the determination of usual blood pressure and the concept of white coat hypertension. (1992) (53)
United States Renal Data System 2006 Annual Data Report Abstract (2007) (51)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study. (1994) (49)
Long-Term Effects of Chlorthalidone Versus Hydrochlorothiazide on Electrocardiographic Left Ventricular Hypertrophy in the Multiple Risk Factor Intervention Trial (2011) (49)
Effects of thiazide diuretics on plasma lipids and lipo-proteins in mildly hypertensive patients: a (2020) (46)
Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. (1996) (45)
Racial and Ethnic Modifiers of the Salt-Blood Pressure Response (1991) (44)
Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2012) (43)
Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group. (1991) (42)
Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation. (1992) (42)
Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation. (2018) (40)
New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. (2002) (39)
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension. (1986) (38)
Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP). (2003) (36)
Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial (2012) (36)
Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. (2009) (34)
The role of physicians in a community-wide program for prevention of cardiovascular disease: the Minnesota Heart Health Program. (1988) (33)
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial (2010) (33)
Dietary Sodium Reduction for Hypertension Prevention and Treatment (1991) (33)
Treatment of Hypertension with Alternative Therapies (THAT) Study: a randomized clinical trial (2002) (31)
The Effects of Amlodipine Compared to Losartan in Patients With Mild to Moderately Severe Hypertension (2003) (31)
Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data. (1997) (31)
alpha 1-antagonists in the treatment of hypertension. (1989) (28)
WITHDRAWN: Dieting to reduce body weight for controlling hypertension in adults. (2008) (27)
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) (1997) (27)
Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension. (2002) (25)
Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication (1988) (24)
Nonpharmacological control of hypertension. (1985) (22)
Smoking patterns among social contacts of smokers, ex-smokers, and never smokers: the Doctors Helping Smokers Study. (1987) (22)
Self-reported hypertension treatment beliefs and practices of primary care physicians in a managed care organization. (2005) (22)
Trial on control of hypertension by nutritional means: three-year results. (1984) (21)
United States Renal Data System 2005 Annual Data Report Abstract (2006) (20)
Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension. (1988) (19)
α-Blockade and thiazide treatment of hypertension A double-blind randomized trial comparing doxazosin and hydrochlorothiazide (1996) (18)
The leukocyte count and risk of lung cancer (1992) (17)
ASPREE-D: Aspirin for the prevention of depression in the elderly (2016) (17)
Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS). (1990) (17)
Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. (1985) (16)
The primary prevention of high blood pressure: a population approach. (1984) (15)
Heart Failure in ALLHAT: Did Blood Pressure Medication at Study Entry Influence Outcome? (2009) (15)
Reserpine and the medical marketplace. (1993) (15)
Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension Study. (1996) (14)
Urinary albumin and N-acetyl-β-D-glucosaminidase excretions in mild hypertension (1994) (14)
Preventive cardiology in practice: a device for risk estimation and counseling in coronary disease. (1979) (14)
Treating hypertension and cardiovascular risk: are there trade-offs? (1990) (11)
How acceptable are financial incentives and written feedback for improving hypertension control? Perspectives from physicians, clinic administrators, and patients. (2002) (11)
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (2016) (11)
Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide. (1996) (11)
Compliance with hypertension treatment. Strategies for improving patient cooperation. (1985) (11)
The multiple risk factor intervention trial in the U.S. A summary of results at four years in special intervention and usual care men. (1983) (11)
A rational approach to hypertension treatment in the older patient. (1992) (11)
Do Type A men drink more frequently than Type B men? Findings in the Multiple Risk Factor Intervention Trial (MRFIT) (1985) (11)
The treatment of mild hypertension study (1991) (10)
Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with hypertension. (2004) (10)
Exercise stress echocardiography in patients with aortic stenosis: impact of baseline diastolic dysfunction and functional capacity on mortality and aortic valve replacement. (2013) (9)
Cardiac status after four years in a trial on nutritional therapy for high blood pressure. (1989) (9)
Metabolic and nutritional factors in hypertension (1991) (9)
Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group. (1994) (9)
Long‐term Effects of a Blood Pressure Survey on Patient Treatment in a Community (1982) (9)
Effects of Anemia and Uremia and a Combination of Both on Cardiovascular Structures (2010) (8)
Enalapril Alone and in Combination With Hydrochlorothiazide in the Treatment of Hypertension: Effect on Treadmill Exercise Performance (1986) (8)
Goals of Antihypertensive Therapy (1995) (8)
The effect of "usual care" on cardiovascular risk factors in a clinical trial. (1984) (8)
Regression of left ventricular hypertrophy. (1996) (8)
Antihypertensive and Metabolic Effects of Concomitant Administration of Terazosin and Methyclothiazide for the Treatment of Essential Hypertension (1992) (7)
Systolic hypertension in the elderly program (SHEP). X, Analysis (1991) (7)
ASSOCIATION OF ANTIHYPERTENSIVE AGENTS AND BLOOD LIPIDS IN A POPULATION‐BASED SURVEY (1994) (6)
Should mild hypertension be treated? Early intervention. (1984) (5)
Statistical design of the treatment of mild hypertension study (TOMHS) (1989) (5)
Measurement of atrial appendage cycle length by transthoracic echocardiography using Doppler tissue imaging (1995) (5)
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study. (2019) (5)
Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss. (1993) (4)
WORKSHOP : METABOLIC AND NUTRITIONAL FACTORS IN HYPERTENSION (1991) (4)
Diuretic treatment of hypertension and changes in plasma lipids over 6 years in the multiple risk factor intervention trial (1984) (4)
Thiazide diuretics and selective alpha blockers: comparison of use in antihypertensive therapy, including possible differences in coronary heart disease risk reduction. (1987) (4)
Diuretics and Plasma Lipids: Effects of thiazides and spironolactone on blood lipids (1982) (4)
Systolic Hypertension of the Elderly Program (SHEP). Part 10: Analysis. (1991) (4)
Increased lipids and lipoproteins in diuretic-treated mild hypertensives (1979) (4)
Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study. (2019) (4)
Corrigendum: Baseline characteristics of participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study (Journals of Gerontology - Series A Biological Sciences and Medical Sciences DOI: 10.1093/gerona/glw342) (2019) (4)
The effects of sodium reduction on control of blood pressure elevation: a review. (1987) (4)
The Drug Treatment of Mild Hypertension in the Multiple Risk Factor Intervention Trial (2012) (4)
Non-responders and patient selection from an echocardiographic perspective (2007) (3)
Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension. (2007) (3)
Workshop II--Hypertension trials and meta-analyses: is there any value for further studies? (1991) (3)
[Control of hypertension by regulating nutrition. The 4-year results]. (1985) (3)
ALLHAT and calcium channel blockers. ALLHAT Research Group. (1997) (3)
Treatment of Hypertension in the Presence of Coexisting Medical Conditions (1994) (3)
Getting to Goal Blood Pressure: Why Reserpine Deserves a Second Look (2007) (3)
Management of hypertension. Potential trade-offs on coronary risk. (1989) (3)
Hypertension therapy in the elderly. (1993) (3)
The effect of smoking on left ventricular structure and function in hypertensive patients (1997) (3)
A Comparison of Antihypertensive Drug Effects on the Progression of Extracranial Carotid Atherosclerosis (2012) (3)
Part 10: Analysis (1991) (3)
Quantitation of left atrial systolic function by Doppler tissue imaging: Clinical validation (1995) (2)
Quality of life with nonpharmacologic treatment of hypertension (2001) (2)
Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trials. (2001) (2)
New developments in the role of α1-adrenergic receptors in cardiovascular disease (1990) (2)
Improvement in Kidney Function: A Real Occurrence (2012) (2)
EFFECTS OF INTENSIVE BLOOD PRESSURE CONTROL ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES MELLITUS: THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) BLOOD PRESSURE TRIAL: PS.3.01 (2010) (2)
Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension. (1994) (2)
Epidemiological and cost implications of antihypertensive treatment for the prevention of cardiovascular disease. (1989) (2)
Chapter 8 – Conducting multicenter and large trials in complementary and alternative medicine (2002) (2)
The effect of dietary sodium and body weight on echocardiographic measures of left ventricular mass among treated hypertensive men and women: Four-year change in the TOMHS study (1994) (2)
α1‐Antagonists in the Treatment of Hypertension (1989) (1)
[Non-pharmacological control of arterial blood pressure in hypertension]. (1983) (1)
Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individuals. (2020) (1)
A nurse-led intervention reduced risk factors, anxiety, and depression in patients waiting for CABG (2002) (1)
Warning—The Physician's Clinical Judgment Can Be Hazardous to Your Health: Withdrawing Drugs in Patients With High Blood Pressure (1997) (1)
1111-211 Narrowing of the widest QRS predicts improvement in functional class and echocardiographic parameters in patients with cardiac resynchronization therapy devices (2004) (1)
PRE-IMPLANT LEFT VENTRICULAR DILATION IS AN IMPORTANT PREDICTOR OF RESPONSE IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY (2010) (1)
Assessment of sodium intake by diet record and by two overnight urine collections in both African-Americans (AA) and whites (W): The treatment of mild hypertension study (TOMHS) (1997) (1)
The White Blood Cell Count as a Risk Factor-Reply (1986) (1)
Abstract 2906: Longitudinal Rotation: An Unrecognized Motion Pattern in Patients with Left Bundle Branch Block and Dilated Cardiomyopathy (2006) (1)
[Prevention and treatment of hypertension at the population level: the Minnesota Heart Health Program]. (1986) (1)
Prevalence and correlates of lower extremity arerial disease in hypertensive patient with carotid atherosclerosis: Baseline results from the Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS) (1993) (1)
State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies. (2021) (1)
Abstract 12268: Reliability and Interobserver Concordance of Echocardiographic Diagnosis of Right Ventricular Size and Systolic Function - A Quality Control Exercise (2011) (1)
872-4 Benefit of biventricular pacing in subsets of patients with heart failure (2004) (1)
Health-related quality of life in the cholesterol reduction in seniors program (1995) (1)
Management of Hypertension: Contributions of Clinical Trials. (2000) (1)
The antihypertensive and lipid lowering treatment to prevent heart attack trial (allhat): update on recruitment and baseline characteristics. (1996) (1)
DID TYPE OF PRIOR ANTIHYPERTENSIVE THERAPY INFLUENCE THE HEART FAILURE RESULTS IN ALLHAT: 6A.6 (2004) (1)
Outcomes of contemporary imaging-guided management of sinus of Valsalva aneurysms. (2020) (1)
P-657: Proteinuria is a predictor of CVD mortality: 16 year mortality follow-up from men in the multiple risk factor intervention trial (MRFIT) (2001) (1)
ADA Evidence Analysis Library (2008) (0)
A060: Amlodipine VS losartan in the treatment of mild to moderately severe hypertension (2000) (0)
Profilaktika i lechenie gipertonii na populiatsionnom urovne: Minnesotskaia programma bor'by s serdechno-sosudistymi bolezniami. (1986) (0)
Possible correlation of stress and DST performance. (1983) (0)
Therapeutic implications of recent clinical trials: age, race, and gender. (1996) (0)
I20HIGHER EDUCATION AND INCOME IS RELATED TO A BETTER URINARY SODIUM:POTASSIUM RATIO IN BLACKS (1995) (0)
Higher Education and Income Are Related to a Better Na:K Ratio in Blacks (1997) (0)
CHARACTERIZATION OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH A NARROW QRS COMPLEX (2013) (0)
H40 Characteristics of the diabetic cohort in the ALLHAT study (1997) (0)
The impact of cardiovascular drugs on sexual function (1998) (0)
F028: Coronary risk meter: A device for rapid estimation of absolute risk of CHD mortality for use in clinical settings (2000) (0)
A061: Amlodipine VS chlorthalidone VS placebo in the treatment of stage I systolic hypertension (2000) (0)
TOMOGRAPHIC DETECTION OF APICAL LEFT VENTRICULAR LEAD AND INFEROLATERAL SCAR PREDICT NON-RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY (2013) (0)
Abstract 3246: Characterization of Super-Response to Cardiac Resynchronization Therapy (2009) (0)
Treatment of mild hypertension study-update of results (1995) (0)
Abstract 167: An Innovative mHealth-based Care Model for Improving Hypertension Control in Stroke Survivors (2017) (0)
Factor VLeiden and other thrombotic risk factors in CHD and myocardial Infarction (0)
Results from the ACCORD BP Trial (2010) (0)
Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications. (2021) (0)
D054: Visit (VAd) and Medication Adherence (MAd) in the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT): Effect of age and other factors (1998) (0)
The Treatment of Mild Hypertension Study-Reply (1993) (0)
THE MULTICENTER ISRADIPINE DIURETIC ATHEROSCLEROSIS STUDY (MIDAS). AUTHORS' REPLY (1997) (0)
Report of group III: prevalence and prognosis (1987) (0)
Long-term Diet and Lifestyle Changes for Control of Mild Hypertension: The Treatmement of Mild Hypertension Stud (TOMHS) (1995) (0)
Re-thinking end-points for cardiovascular primary prevention trials in the elderly - ASPREE as a working example (2014) (0)
Management of multi-center trials: A comparison of investigator initiated studies and other administrative models (1989) (0)
Different classes of antihypertensive drug treatment in relation to self-reported health in post-menopausal women: The women's health initiative (2000) (0)
Clinical and Population Studies Long-Term Effects of Chlorthalidone Versus Hydrochlorothiazide on Electrocardiographic Left Ventricular Hypertrophy in the Multiple Risk Factor Intervention Trial (2011) (0)
DEFORMATION IMAGING IS AN INDEPENDENT PREDICTOR OF OUTCOMES IN ASYMPTOMATIC AORTIC STENOSIS WITH NORMAL EJECTION FRACTION (2012) (0)
Authors' response (2011) (0)
Abstracts of the 81st Annual Conference on Cardiovascular Disease Epidemiology Atherosclerosis: Quantitative Imaging, Risk Factors, Prevalence, and Change (2005) (0)
K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
[Occupational medicine aspects in gastroenterologic diseases]. (1990) (0)
1125-137 Progression of ascending aortic dilatation in congenital bicuspid aortic valve patients: Assessment by serial magnetic resonance imaging (2004) (0)
PT254 The Aspirin in Reducing Events in the Elderly Trial (ASPREE): Progress Report (2014) (0)
Abstract 2814: Dyssynchrony Transthoraccic Echocardiogram As A Predictor Of Response To Cardiac Resynchronization. (2007) (0)
Abstract 5924: Epicardial vs. Coronary Sinus Lead Placement for Cardiac Resynchronization Therapy in the Treatment of Heart Failure (2008) (0)
998-120 Left Ventricular Systolic Performance Changes in Mild Hypertensive Subjects Treated with Antihypertensive Monotherapy or Placebo: The Treatment of Mild Hypertension Study (TOMHS) (1995) (0)
SELF-REPORTED FUNCTIONAL CAPACITY BY DASI AND KCCQ ARE POORLY ASSOCIATED WITH OBJECTIVE MEASURES ON CARDIOMETABOLIC STRESS TESTING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (2018) (0)
IL-6 signalling in chronic kidney disease(CKD) and peritoneal dialysis (PD) patients [Abstract] (2008) (0)
PREDICTORS OF LONG–TERM OUTCOMES IN PATIENTS WITH MODERATE–SEVERE AND SEVERE MYXOMATOUS MITRAL REGURGITATION UNDERGOING EXERCISE ECHOCARDIOGRAPHY (2013) (0)
Trial the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in Clinical Events in High-Risk Hypertensive Patients Randomly (2006) (0)
P-450: Reasons for going off study medication in the treatment of mild hypertension study (TOMHS): Side effects or something else? (2001) (0)
Clinically unrecognized MI accounts for a significant proportion of all MIs occurring in the elderly (2000) (0)
Abstract 16525: Exercise Stress Echocardiography in Patients with Aortic Stenosis: Impact of Baseline Diastolic Dysfunction and Functional Capacity on Mortality and Aortic Valve Replacement (2012) (0)
New multicenter trials in hypertension (1991) (0)
Review of McDowell's letter (1984) (0)
THE TREATMENT OF MILD HYPERTENSION STUDY. AUTHORS' REPLY (1993) (0)
Left ventricular function and remodeling in stage I hypertension: The treatment of mild hypertension study (1996) (0)
Nefarmakologicheskaia reguliatsiia arterial'nogo davleniia pri gipertonii. (1983) (0)
Abstract 12026: Development of a Consensus Document to Improve Multi-Reader Concordance and Accuracy of AR Severity Grading by Echocardiography: A Study with Cardiac MRI Correlation (2011) (0)
Session IV. Demographic Modifiers of Salt‐Blood Pressure Relation (1991) (0)
The interactive effect of body size and renin-angiotensin axis on blood pressure response to oral salt loading in normotensive African-Americans. (1999) (0)
^-Antagonists in the Treatment of Hypertension (2005) (0)
ABNORMAL ANKLE-BRACHIAL INDEX PREDICTS AN ABNORMAL STRESS TEST BUT DOES NOT CORRELATE WITH ISCHEMIC BURDEN (2011) (0)
Poor blood pressure control among treated hypertensives was not attributable to a 'white-coat' effect. (1997) (0)
Plans for analysis of the shep trial (1990) (0)
Plenary Session III: New Concepts: Higher Goals, Unmet Needs and New Therapeutic Targets (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard H. Jr. Grimm?

Richard H. Jr. Grimm is affiliated with the following schools: